ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Up 43.5% in March

ENDRA Life Sciences Inc. (NASDAQ:NDRA) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 40,600 shares, an increase of 43.5% from the February 28th total of 28,300 shares. Currently, 7.6% of the company’s shares are short sold. Based on an average daily volume of 19,800 shares, the short-interest ratio is presently 2.1 days.

ENDRA Life Sciences Price Performance

Shares of NASDAQ:NDRA traded down $0.01 on Friday, hitting $4.24. 2,336 shares of the company’s stock were exchanged, compared to its average volume of 99,756. The business’s 50 day simple moving average is $4.63 and its two-hundred day simple moving average is $5.99. The stock has a market capitalization of $2.28 million, a price-to-earnings ratio of 0.00 and a beta of 0.43. ENDRA Life Sciences has a 12 month low of $3.15 and a 12 month high of $875.00.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.